Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
587,232
+93,698
+19% +$268K ﹤0.01% 1142
2025
Q4
$1.22M Buy
493,534
+476,170
+2,742% +$1.13M ﹤0.01% 1235
2025
Q3
$37.9K Sell
17,364
-104,784
-86% -$240K ﹤0.01% 1589
2025
Q2
$304K Sell
122,148
-107,375
-47% -$261K ﹤0.01% 1504
2025
Q1
$555K Sell
229,523
-7,556
-3% -$15.1K ﹤0.01% 1465
2024
Q4
$436K Sell
237,079
-196,393
-45% -$434K ﹤0.01% 1588
2024
Q3
$1.03M Buy
+433,472
New +$972K ﹤0.01% 1283

Other funds holding ABEV

Amundi's ABEV Position: Q1 2026 in Review

Amundi increased its Ambev (ABEV) stake by 19% in Q1 2026, buying an estimated $268K and bringing the position to 587,232 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Amundi first reported a position in ABEV in Q3 2024 and has held it in 7 quarters since. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Amundi held 587,232 shares of Ambev worth $1.71M as of Q1 2026.
  • Amundi bought 93,698 Ambev shares in Q1 2026, an estimated $268K.
  • Ambev made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1142 holding.
  • Amundi first reported a position in Ambev in Q3 2024 and has held it in 7 quarters since.
  • 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.